ANTIDEPRESSANT INTERACTIONS WITH 5-HYDROXYTRYPTAMINE3 RECEPTOR-BINDING SITES

被引：28
|
作者：
SCHMIDT, AW [1 ]
PEROUTKA, SJ [1 ]
机构：
[1] STANFORD UNIV,MED CTR,DEPT NEUROL,STANFORD,CA 94305
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1989年 / 163卷 / 2-3期
关键词：
D O I：
10.1016/0014-2999(89)90215-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：397 / 398
页数：2
相关论文
共 50 条
  • [31] THEORETICAL STUDIES ON INTERACTIONS BETWEEN PHARMACOLOGICAL MODELS AND IONIC RECEPTOR-BINDING SITES
    HOLTJE, HD
    ARCHIV DER PHARMAZIE, 1978, 311 (01) : 2 - 11
  • [32] Probing the role of a conserved M1 proline residue in 5-hydroxytryptamine3 receptor gating
    Dang, H
    England, PM
    Farivar, SS
    Dougherty, DA
    Lester, HA
    MOLECULAR PHARMACOLOGY, 2000, 57 (06) : 1114 - 1122
  • [33] ANALYSIS OF TANDOSPIRONE (SM-3997) INTERACTIONS WITH NEUROTRANSMITTER RECEPTOR-BINDING SITES
    HAMIK, A
    OKSENBERG, D
    FISCHETTE, C
    PEROUTKA, SJ
    BIOLOGICAL PSYCHIATRY, 1990, 28 (02) : 99 - 109
  • [34] The role of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the regulation of gut motility in the ferret
    Nagakura, Y
    Kiso, T
    Ito, H
    Miyata, K
    Yamaguchi, T
    LIFE SCIENCES, 2000, 66 (24) : PL331 - PL338
  • [35] THE EFFECT OF THE 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONIST ALOSETRON ON BASAL WATER AND ELECTROLYTE TRANSPORT IN HUMAN JEJUNUM
    BEARCROFT, CP
    ANDRE, EA
    FARTHING, MJG
    GASTROENTEROLOGY, 1994, 106 (04) : A221 - A221
  • [36] AFFINITY OF MUSCARINIC RECEPTOR ANTAGONISTS FOR 3 PUTATIVE MUSCARINIC RECEPTOR-BINDING SITES
    DELMENDO, RE
    MICHEL, AD
    WHITING, RL
    BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) : 457 - 464
  • [37] EVIDENCE FOR PRESYNAPTIC 5-HYDROXYTRYPTAMINE3 RECOGNITION SITES ON VAGAL AFFERENT TERMINALS IN THE BRAIN-STEM OF THE FERRET
    LESLIE, RA
    REYNOLDS, DJM
    ANDREWS, PLR
    GRAHAMESMITH, DG
    DAVIS, CJ
    HARVEY, JM
    NEUROSCIENCE, 1990, 38 (03) : 667 - 673
  • [38] 5-HYDROXYTRYPTAMINE3 RECEPTORS MEDIATE TACHYCARDIA IN CONSCIOUS INSTRUMENTED DOGS
    WILSON, H
    COFFMAN, WJ
    COHEN, ML
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 252 (02): : 683 - 688
  • [39] The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: Tropisetron, ondansetron and dolasetron
    Paech, MJ
    Rucklidge, MWM
    Banks, SL
    Gurrin, LC
    Orlikowski, CEP
    Pavy, TJG
    ANAESTHESIA AND INTENSIVE CARE, 2003, 31 (01) : 11 - 17
  • [40] RECEPTOR-BINDING PROFILE OF QUINUPRAMINE, A NEW TRICYCLIC ANTIDEPRESSANT
    SAKAMOTO, H
    YOKOYAMA, N
    KOHNO, S
    OHATA, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 (04): : 455 - 460
12345